Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29658
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorORTIZ, Rafael C.-
dc.contributor.authorLOPES, Nathalia M.-
dc.contributor.authorAMOR, Nadia G.-
dc.contributor.authorPONCE, Jose B.-
dc.contributor.authorSCHMERLING, Claudia K.-
dc.contributor.authorLARA, Vanessa S.-
dc.contributor.authorMOYSES, Raquel A.-
dc.contributor.authorRODINI, Camila O.-
dc.date.accessioned2018-11-21T17:09:21Z-
dc.date.available2018-11-21T17:09:21Z-
dc.date.issued2018-
dc.identifier.citationJOURNAL OF ORAL PATHOLOGY & MEDICINE, v.47, n.8, p.740-747, 2018-
dc.identifier.issn0904-2512-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/29658-
dc.description.abstractBackgroundTumour metastasis has been associated with cancer stem cells, a small population with stem-like cells properties, higher rate of migration and metastatic potential compared to cells from the tumour bulk. Our aim was to evaluate the immunoexpression of the putative cancer stem cell biomarkers ALDH1 and CD44 in primary tumour and corresponding metastatic lymph nodes. MethodsTumour tissue specimens (n = 50) and corresponding metastatic lymph nodes (n = 25) were surgically obtained from 50 patients with oral squamous cell carcinoma and submitted to immunohistochemistry. CD44 and ALDH1 were semi-quantitatively scored according to the proportion and intensity of positive cells within the invasive front and metastatic lymph nodes as a whole. A combined score was obtained by multiplying both parameters and later dichotomized into a final score classified as low (2) or high (>2) immunoexpression. ResultsALDH1 immunoexpression and CD44 immunoexpression were detected in both tumour sites, although the means of ALDH1 (P = .0985) and CD44 (P = .4220) cells were higher in metastasis compared to primary tumours. ALDH1(high) was positively associated (P = .0184) with angiolymphatic invasion, while CD44(high) was positively associated (P = .0181) with metastasis (N+). At multivariate analysis, CD44 significantly increased the odds of lymph node metastasis, regardless of T stage (OR = 8.24; 1.64-65.64, P = .0088). ConclusionsCD44 immunoexpression was a significant predictor of lymph node metastasis, while ALDH1(high) immunostaining was associated with angiolymphatic invasion. Altogether, it suggests that immunoexpression of CD44 and ALDH1 links the cancer stem cell phenotype with oral squamous cell carcinoma invasion and metastasis.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/07245-9, 2015-06945-2]-
dc.language.isoeng-
dc.publisherWILEY-
dc.relation.ispartofJournal of Oral Pathology & Medicine-
dc.rightsrestrictedAccess-
dc.subjectALDH1-
dc.subjectcancer stem cells-
dc.subjectCD44-
dc.subjectcervical metastatic lymph nodes-
dc.subjectoral squamous cell carcinoma-
dc.subject.otheraldehyde dehydrogenase 1-
dc.subject.othercancer-
dc.subject.othermarker-
dc.subject.othermetaanalysis-
dc.subject.otherhead-
dc.titleCD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma-
dc.typearticle-
dc.rights.holderCopyright WILEY-
dc.identifier.doi10.1111/jop.12734-
dc.identifier.pmid29791975
dc.subject.wosDentistry, Oral Surgery & Medicine-
dc.subject.wosPathology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalORTIZ, Rafael C.:Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil-
hcfmusp.author.externalLOPES, Nathalia M.:Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil-
hcfmusp.author.externalAMOR, Nadia G.:Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil-
hcfmusp.author.externalPONCE, Jose B.:Univ Ctr Adamantina, Dept Pathol, Adamantina, SP, Brazil-
hcfmusp.author.externalSCHMERLING, Claudia K.:Sch Med Sao Paulo, Clin Hosp, Dept Anat Pathol, Sao Paulo, Brazil-
hcfmusp.author.externalLARA, Vanessa S.:Univ Sao Paulo, Bauru Sch Dent, Dept Surg Stomatol Pathol & Radiol, Bauru, SP, Brazil-
hcfmusp.author.externalRODINI, Camila O.:Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil-
hcfmusp.description.beginpage740-
hcfmusp.description.endpage747-
hcfmusp.description.issue8-
hcfmusp.description.volume47-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000443808200004-
hcfmusp.origem.id2-s2.0-85052796716-
hcfmusp.publisher.cityHOBOKEN-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceBiddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059-
hcfmusp.relation.referenceBoxberg M, 2018, HISTOPATHOLOGY, V73, P559, DOI 10.1111/his.13496-
hcfmusp.relation.referenceChen JQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-15-
hcfmusp.relation.referenceDe Craene B, 2013, NAT REV CANCER, V13, P110-
hcfmusp.relation.referenceEl-Aziz YSA, 2017, TANTA DENT J, V14, P67-
hcfmusp.relation.referenceHabiba U, 2017, ONCOL LETT, V13, P321, DOI 10.3892/ol.2016.5379-
hcfmusp.relation.referenceHolah NS, 2017, J CLIN DIAGN RES, V11, pEC17, DOI 10.7860/JCDR/2017/22671.9291-
hcfmusp.relation.referenceHuang CF, 2014, J ORAL PATHOL MED, V43, P492, DOI 10.1111/jop.12159-
hcfmusp.relation.referenceJoshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699-
hcfmusp.relation.referenceKendall K, 2013, J CANCER RES THER, V1, P111-
hcfmusp.relation.referenceKitamura H, 2013, MODERN PATHOL, V26, P24-
hcfmusp.relation.referenceKokko LL, 2011, ORAL ONCOL, V47, P510, DOI 10.1016/j.oraloncology.2011.03.026-
hcfmusp.relation.referenceKoukourakis MI, 2012, BRIT J CANCER, V106, P853-
hcfmusp.relation.referenceLiu JF, 2015, INT J CLIN EXP MED, V8, P8425-
hcfmusp.relation.referenceMack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360-
hcfmusp.relation.referenceMannelli G, 2015, CLIN OTOLARYNGOL, V40, P312, DOI 10.1111/coa.12368-
hcfmusp.relation.referenceMichifuri Y, 2012, PATHOL INT, V62, P684, DOI 10.1111/j.1440-1827.2012.02851.x-
hcfmusp.relation.referenceMrgritescu D, 2011, ROM J MORPHOL EMBRYO, V52, P993-
hcfmusp.relation.referenceNassar D, 2016, ANNU REV PATHOL-MECH, V11, P76-
hcfmusp.relation.referenceOsman TA, 2014, THESIS-
hcfmusp.relation.referencePedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011-
hcfmusp.relation.referenceQian X, 2015, CRIT REV ONCOL HEMAT, V95, P337, DOI 10.1016/j.critrevonc.2015.03.009-
hcfmusp.relation.referenceSeino S, 2016, J ORAL PATHOL MED, V45, P180, DOI 10.1111/jop.12348-
hcfmusp.relation.referenceShakib PA, 2015, DENT RES J ISFAHAN, V12, P6-
hcfmusp.relation.referenceSun DY, 2016, BIOMED RES, V27, P291-
hcfmusp.relation.referenceVisvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781-
hcfmusp.relation.referenceWang PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052088-
hcfmusp.relation.referenceWu TF, 2017, EUR J PHARM SCI, V101, P243, DOI 10.1016/j.ejps.2017.02.020-
hcfmusp.relation.referenceYu Z, 2012, INT J BIOCHEM CELL B, V44, P2151-
hcfmusp.relation.referenceZhou CY, 2014, ORAL ONCOL, V50, P1144, DOI 10.1016/j.oraloncology.2014.08.018-
dc.description.indexMEDLINE-
dc.identifier.eissn1600-0714-
hcfmusp.citation.scopus18-
hcfmusp.scopus.lastupdate2022-06-16-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/28
LIM/28 - Laboratório de Cirurgia Vascular e da Cabeça e Pescoço

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_ORTIZ_CD44_and_ALDH1_immunoexpression_as_prognostic_indicators_of_2018.PDF
  Restricted Access
publishedVersion (English)1.46 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.